Abstract Details

Title What Is the Risk of Seizure Recurrence during Antiepileptic Drug Titration in Newly Diagnosed Epilepsy?

Topic Epilepsy

Presentation(s) (-)

Poster/Presentation
Number 004

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Agessandro Abrahao, Jr., MD (Sunnybrook Health Sciences Centre - University of Toronto)	Dr. Abrahao has nothing to disclose.
Joash T. Lazarus, MD (Atlanta Neuroscience Institute)	Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Lazarus has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers squib. Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for USWM. Dr. Lazarus has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for arcadia. Dr. Lazarus has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for acorda. Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for allergan. The institution of Dr. Lazarus has received research support from Genentech.
Amza Ali, MD, FRCP, FAAN (Epilepsy Centre of Jamaica)	No disclosure on file
	No disclosure on file
	No disclosure on file
Jorge L. Juncos, MD (Emory University School of Medicine Brain Helath Clinic)	No disclosure on file